Wells Fargo’s ENvue Medical Inc FEED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$107 Buy
+45
New +$97 ﹤0.01% 6495
2024
Q2
Hold
0
-$14 7264
2024
Q1
Hold
0
7219
2023
Q4
Hold
0
7296
2023
Q3
Hold
0
7140
2023
Q2
Hold
0
7105
2023
Q1
Hold
0
7188
2022
Q4
Hold
0
7024
2022
Q3
Hold
0
7119
2022
Q2
Sell
-1
Closed -$1.58K 7249
2022
Q1
$3K Buy
+1
New +$1.89K ﹤0.01% 6588
2021
Q4
Hold
0
7609
2021
Q3
Hold
0
7323
2021
Q2
Hold
0
7250
2021
Q1
Hold
0
7204
2020
Q4
Hold
0
6822
2020
Q3
Hold
0
6692
2020
Q2
Hold
0
6633
2020
Q1
Hold
0
6588

Other funds holding FEED

Wells Fargo's FEED Position: Q1 2026 in Review

Wells Fargo opened a new position in ENvue Medical Inc (FEED) in Q1 2026: 45 shares worth $107. The stake represents ﹤0.01% of the portfolio and ranks #6495 among its holdings. This is a return to the name: Wells Fargo previously reported a position in FEED as recently as Q1 2022.

Wells Fargo first reported a position in FEED in Q1 2022 and has held it in 2 quarters since. The position peaked at $3K in Q1 2022. 13 funds tracked by Wall St. Rank hold FEED as of Q1 2026.

  • Wells Fargo held 45 shares of ENvue Medical Inc worth $107 as of Q1 2026.
  • ENvue Medical Inc was a new Wells Fargo position in Q1 2026.
  • ENvue Medical Inc made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #6495 holding.
  • Wells Fargo first reported a position in ENvue Medical Inc in Q1 2022 and has held it in 2 quarters since.
  • Wells Fargo's ENvue Medical Inc position peaked at $3K in Q1 2022.
  • 13 funds tracked by Wall St. Rank held ENvue Medical Inc as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.